Speeding Up Access to Affordable Generic and Biosimilar Medications
This law aims to accelerate the market entry of cheaper drug alternatives (generics and biosimilars). It sets stricter deadlines and increases transparency for original drug manufacturers who must provide samples for testing to generic developers. Citizens should benefit from the faster availability of affordable medication options, potentially lowering healthcare costs.
Key points
Reduces the waiting time for generic drug manufacturers to obtain necessary samples for testing and approval of cheaper alternatives.
Requires brand-name pharmaceutical companies to publicly disclose their policies for providing samples, increasing transparency.
Facilitates faster access to affordable medicines by removing bureaucratic barriers and delays in the development process.
Expired
Citizen Poll